Document Detail

Protein drug stability: a formulation challenge.
MedLine Citation:
PMID:  15803194     Owner:  NLM     Status:  MEDLINE    
The increasing use of recombinantly expressed therapeutic proteins in the pharmaceutical industry has highlighted issues such as their stability during long-term storage and means of efficacious delivery that avoid adverse immunogenic side effects. Controlled chemical modifications, such as substitutions, acylation and PEGylation, have fulfilled some but not all of their promises, while hydrogels and lipid-based formulations could well be developed into generic delivery systems. Strategies to curb the aggregation and misfolding of proteins during storage are likely to benefit from the recent surge of interest in protein fibrillation. This might in turn lead to generally accepted guidelines and tests to avoid unforeseen adverse effects in drug delivery.
Sven Frokjaer; Daniel E Otzen
Related Documents :
17375554 - Self-assembled surfactant nano-structures important in drug delivery: a review.
16472224 - Reversible covalent chemistry in drug delivery.
8144794 - Prospects for site-specific delivery of pharmacologic and molecular therapies.
11943384 - Biodegradable injectable in situ forming drug delivery systems.
3693874 - Are there ethnic differences in lithium pharmacokinetics and side-effects?
15738314 - Recruiting drug-using men who have sex with men into behavioral interventions: a two-st...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  4     ISSN:  1474-1776     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-01     Completed Date:  2005-05-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  298-306     Citation Subset:  IM    
Department of Pharmaceutics, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen O, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Delivery Systems
Drug Design*
Drug Stability
Models, Molecular
Recombinant Proteins* / administration & dosage,  chemistry,  therapeutic use
Reg. No./Substance:
0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The evolving field of biodefence: therapeutic developments and diagnostics.
Next Document:  Chemistry-to-gene screens in Caenorhabditis elegans.